Search
for
Sort by
Research 481–510 of 1000+
- Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation
- The Role of Janus Kinase Inhibitors in Dermatology
- Female Serum HER2 Expression: Its Association With Metabolic Syndrome and Treatment Drug Response
- Using a Natural Clay Mineral as an Active Drug Carrier to Promote Hair Growth
- Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions, 1–30 September 2016
- A review for cell-based screening methods in drug discovery
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- Ultrasound-responsive hydrogel with ROS scavenging and NO controllable release capabilities for accelerated healing of diabetic wounds
- JAK inhibitors in dermatology: The promise of a new drug class
- Review of applications of microneedling in dermatology
- Reversal of Alopecia Universalis by Tofacitinib: A Case Report
- Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing
- Role of skin enzymes in metabolism of topical drugs
- Issues in the Treatment of Epilepsy
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- 202 Activation of breast cancer cell proliferation by ROR-alpha through aromatase promoter
- Triple-layered core-shell fiber dressings with enduring platelet conservation and sustained growth factor release abilities for chronic wound healing
- Novel Strategies for Androgenetic Alopecia Therapy: Integrating Multifunctional Plant Extracts with Nanotechnology for Advanced Cutaneous Drug Delivery
- Recent advances in 3D bioprinting of tissues and organs for transplantation and drug screening
- The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial
- Real-World Effectiveness, Safety, and Tolerability of Cetosomal Minoxidil 5% Alone and a Fixed Drug Combination of Cetosomal Minoxidil 5% With Finasteride 0.1% in the Management of Androgenetic Alopecia (Inbilt Study)
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
- Hair Growth in a Patient with Alopecia Areata on Tocilizumab
- Adaptive 3D Self‐Assembly of Colorectal Cancer Cells With Unchanged Tumor Phenotype and Drug Sensitivity